Article
Regulatory expert appointed to lead West Coast US client engagement for G&L
Posted on the 3rd June 2024
![Richard Edmunds](https://gandlscientific.s3-assets.com/Richard-Edmunds.jpg)
Another exciting development for G&L.
G&L Healthcare Advisors is delighted to announce that Richard Edmunds, a 25-year veteran in regulatory affairs, will take on a new client engagement role and lead our US West coast business expansion, based out of G&L’s San Diego, California office.
Bringing decades of regulatory and clinical development experience, Richard will partner with both biotech and pharma customers to expedite drug development and product launch. Richard has a strong track record of helping over 50 companies secure regulatory approval.
Richard brings a unique and compelling combination of technical expertise and business acumen that helps our clients achieve their goals, whatever their stage of development.
He has assisted clients in initiating proof-of-concept studies and securing funding; reaching Ph1/2 clinical trial inflection point; gearing up for product approval and launch; increasing revenue through global expansion; or implementing cost-effective models for post-approval activities, technology solutions, and more.
Commenting on Richard’s appointment, G&L’s COO Dave Yungvirt said: “We are excited that Richard has agreed to help take G&L to the next level, as part of our continued growth, serving our West Coast clients to ultimately meet patient needs.”
Schedule your appointment with Richard today: https://calendly.com/redmunds-...